Alpha DNA Investment Management’s iShares MSCI EAFE Growth ETF EFG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,938
Closed -$213K 129
2021
Q4
$213K Buy
+1,938
New +$212K 0.13% 99
2021
Q2
Sell
-1,486
Closed -$149K 259
2021
Q1
$149K Sell
1,486
-103
-6% -$10.5K 0.17% 108
2020
Q4
$160K Buy
+1,589
New +$150K 0.17% 111

Other funds holding EFG

Alpha DNA Investment Management's EFG Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of iShares MSCI EAFE Growth ETF (EFG) in Q1 2022, closing a stake of 1,938 shares — an estimated $213K sold.

Alpha DNA Investment Management first reported a position in EFG in Q4 2020 and held it in 3 quarters. The position peaked at $213K in Q4 2021. 718 funds tracked by Wall St. Rank hold EFG as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining iShares MSCI EAFE Growth ETF position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,938 iShares MSCI EAFE Growth ETF shares in Q1 2022, an estimated $213K.
  • Alpha DNA Investment Management first reported a position in iShares MSCI EAFE Growth ETF in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's iShares MSCI EAFE Growth ETF position peaked at $213K in Q4 2021.
  • 718 funds tracked by Wall St. Rank held iShares MSCI EAFE Growth ETF as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.